Main Library
HHS aims to use value-based care payment models to lower drug prices

HHS aims to use value-based care payment models to lower drug prices

September 9, 2021Robert KingNo CommentsFierce HealthcarePharmacy Services

The Department of Health and Human Services wants to test models that would pay drugs based on their clinical value as part of a new plan to tackle high prices.

The plan released Thursday lays out several administrative tools the agency plans to take to address high prices. It also calls on Congress to adopt several reforms such as giving Medicare price negotiation authority and cap Part D catastrophic spending.

“By promoting negotiation, competition, and innovation in the health care industry, we will ensure cost fairness and protect access to care,” HHS Secretary Xavier Becerra said in a statement Thursday.

Full Article

: CMMI, drug prices, HHS, Pharmaceuticals

Related Posts

Going Beyond Compliance: How Payers Can Embrace Healthcare Interoperability

June 28, 2021Garrett Schmitt

The Little-Known Agency That’s Trying To Boil The Ocean—A Look At CMMI’s Decade Of Trying To Change Medicare & Medicaid

July 26, 2021Garrett Schmitt

MedPAC: Overhaul MA payments and streamline CMMI models

June 16, 2021Garrett Schmitt

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Value-based care creating a new era of interoperability
  • ACO REACH And Advancing Equity Through Value-Based Payment, Part 1
  • Medicare Shared Savings Program: Celebrating 10 Years and Looking Forward to the Future
  • Considerations for Social Determinants of Health Screening Design
  • RECORDED WEBINAR: 5 Key Components for Organizational Growth Within Value-Based Care
 
  • Main Lobby
  • Exhibit Hall
  • Events
  • Exhibit With Us
  • Board Room
  • Library
  • Contact Us